.

United Therapeutics reported $29.7M in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Amarin AMRN:US $ 35.81M 13.57M
Ardelyx ARDX:US $ 0.14M 0.05M
Baxter International BAX:US $ 2289M 68M
Bayer BAYN:GR € 5680M 504M
Biocryst Pharmaceuticals BCRX:US $ 0.25M 0.01M
Biogen BIIB:US $ 484M 269.9M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Emergent Biosolutions EBS:US $ 169.8M 13.9M
Esperion Therapeutics ESPR:US $ 9.18M 2.05M
Gilead Sciences GILD:US $ 1442M 18M
GlaxoSmithKline GSK:LN 213600M 55400M
Halozyme Therapeutics HALO:US $ 33.94M 18.02M
Insmed INSM:US $ 16.4M 4.2M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
Intra Cellular Therapies ITCI:US $ 4.65M 1.5M
IONIS PHARMACEUT IONS:US $ 4.74M 0.57M
Johnson & Johnson JNJ:US $ 7919M 321M
Moderna Inc MRNA:US 1.38B 364M
Pfizer PFE:US $ 8671M 1339M
Ptc Therapeutics PTCT:US $ 9.64M 0.5M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M
Sarepta Therapeutics SRPT:US $ 37.8M 6.35M
Seattle Genetics SGEN:US $ 106.1M 18.47M
Teva Pharmaceutical TEVA:IT 1.96B 99M
United Therapeutics UTHR:US $ 29.7M 3.8M
Vertex Pharmaceuticals VRTX:US $ 261.8M 16M